On September 26, 2025, the Department of Justice announced that device manufacturer Semler Scientific had agreed to pay nearly $30 million, and its former distributor Bard Peripheral Vascular had agreed to pay an additional $7.2 million, in connection with the settlement of a whistleblower lawsuit filed under the qui tam provisions of the federal False […]
We have written previously (here, here, and here) about a marked increase in cusoms-related fraud enforcement, particularly in light of the current administration’s focus on increased tariffs on imported goods. This enforcement has included both criminal charges and civil lawsuits under the False Claims Act (FCA). On August 29, 2025, the Department of Justice (DOJ) […]
On July 17, 2025, the Department of Justice (DOJ) and the States of Colorado, Georgia, and South Carolina announced that the former CEO and owner of a now-defunct laboratory agreed to a consent judgment of over $27.5 million under the False Claims Act (FCA), “acknowledging there is a likelihood he would be found liable in […]
The False Claims Act (FCA) is the government’s most powerful civil tool to investigate and pursue claims against businesses and individuals who submit false or fraudulent claims to the government. Every year, the Department of Justice (DOJ) obtains billions of dollars in FCA settlements and judgments (mostly settlements), the majority of which involve healthcare providers […]
For more information or to arrange a consultation, please contact us by telephone at (404) 233-4171 or online by submitting the form below. The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship nor create an expectancy of a potential attorney-client relationship. Do not submit information which is confidential or time sensitive, as it may not be treated as such.